Biotransplant Inc Sample Contracts

AutoNDA by SimpleDocs
Exhibit 10.7 SHAREHOLDERS AGREEMENT Date: 5 April 1994
Shareholder Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Victoria
BIOTRANSPLANT INC. ("BTI")
Shareholders' Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations
WITNESSETH:
Supply Agreement • November 14th, 1996 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
BY-LAWS
By-Laws • December 10th, 2001 • Biotransplant Inc • Pharmaceutical preparations
AMONG
Shareholder Agreement • November 13th, 2000 • Biotransplant Inc • Pharmaceutical preparations
AGREEMENT
Confidentiality Agreement • May 15th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
SECTION 1. DEFINITIONS
Collaboration and License Agreement • November 12th, 1997 • Biotransplant Inc • Pharmaceutical preparations • New York
WITNESSETH:
License Agreement • April 10th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Maryland
August 19, 2002
Employment Agreement • November 19th, 2002 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts
FIRST AMENDMENT TO MASTER LOAN AND SECURITY AGREEMENT
Master Loan and Security Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Illinois

THIS FIRST AMENDMENT TO MASTER LOAN AND SECURITY AGREEMENT (the “Amendment”), dated as of May 15, 2001, by and between Eligix, Inc. (the “Borrower” or “Eligix”), a Delaware corporation, having its principal place of business and chief executive office at 200 Boston Avenue, Medford, Massachusetts, 02139, and TRANSAMERICA BUSINESS CREDIT CORPORATION (the “Lender”), a Delaware corporation, having its principal office at Riverway II, West Office Tower, 9399 West Higgins Road, Rosemont, Illinois, 60018.

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AGREEMENT
Confidentiality Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • California

THIS AGREEMENT is made effective as of the 2nd day of June, 2000, (the “Effective Date”) by and between COULTER PHARMACEUTICAL, INC., a Delaware corporation, located at 600 Gateway Boulevard, South San Francisco, CA 94080 (“Coulter”), and Eligix, Inc., located at 200 Boston Avenue, Medford, MA 02155 (“Eligix”).

MASTER LOAN AND SECURITY AGREEMENT
Master Loan and Security Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Illinois

THIS AGREEMENT dated as of July 28, 1999, is made by Eligix, Inc. (the "Borrower"), a Delaware corporation having its principal place of business and chief executive office at 200 Boston Avenue, Medford, Massachusetts, 02139 in favor of Transamerica Business Credit Corporation, a Delaware corporation (the "Lender"), having its principal office at Riverway II, West Office Tower, 9399 West Higgins Road, Rosemont, Illinois 60018.

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE, ASSIGNMENT AND SUPPLY AGREEMENT
License, Assignment and Supply Agreement • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Delaware

THIS LICENSE, ASSIGNMENT AND SUPPLY AGREEMENT (the "Agreement”) is effective as of February 13, 1997 (the "Effective Date"), by and between COULTER CORPORATION (hereinafter "Coulter Corporation") and its wholly-owned subsidiary COULTER INTERNATIONAL CORPORATION (hereinafter "CIC"), each having its respective principal place of business at 11800 S.W. 147th Avenue, Miami, Florida 33196, and COULTER CELLULAR THERAPIES, INC. (hereinafter "CCTI"), having its principal place of business at 3000 Sand Hill Road, Building 3, Suite 255, Menlo Park, California 94025. Coulter Corporation and its Affiliates (including, but not limited to, CIC) shall be referred to collectively in this Agreement as "Coulter".

BETWEEN BIOTRANSPLANT INC. ("BTI")
Agreement to Further Vary Shareholders' Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations
CUMMINGS PROPERTIES MANAGEMENT, INC. STANDARD FORM COMMERCIAL LEASE
Commercial Lease • August 14th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Massachusetts

In consideration of the covenants herein contained, Cummings Properties Management, Inc., hereinafter called LESSOR, does hereby lease to Coulter Cellular Therapies, Inc. (a Massachusetts corporation), 20 Hampden Street, Roxbury, Massachusetts 02119 hereinafter called LESSEE, the following described premises, hereinafter called the leased premises: approximately 33,048 square feet (including 10.65% common area) at 200 Boston Avenue, Suites 2100, 2400, 2600, 2900 and 1475, Medford, Massachusetts 02155.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!